Konstantin Yenkoyan: Neuroscience Week 2026 Continues in Yerevan
Konstantin Yenkoyan, Scientist in Chief at Cobrain Center, Vice Rector for science at Yerevan State Medical University named after Mkhitar Heratsi, shared a post on LinkedIn:
“Neuroscience Week 2026 continues in Yerevan | Day 2 and Day 3
Another two intense and inspiring days at the COBRAIN Center of YSMU.
From stress biology and neuroinflammation to neurodegeneration, psychiatry, cognition, neurodevelopment, and translational neuroscience – discussions continued across multiple
exciting directions of modern brain science.
Alongside high-level international lectures, Day 2 and Day 3 included active poster sessions, the COBRAIN Journal Club, interactive discussions, and sharp scientific questions
from students and young researchers.
Good poster presentations were also delivered by YSMU COBRAIN young researchers – Margarita Mirumyan, Ella Baghdasaryan, and Hamlet Torosyan.
Researchers and speakers from more than 15 countries continue sharing ideas, presenting new findings, and building future collaborations in neuroscience and biological psychiatry.
What makes Neuroscience Week especially valuable is the combination of scientific excellence, international exchange, and the energy of the next generation of neuroscientists.
and yes, Armenian coffee discussions between sessions remain an important part of the event.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery